Silla





Silla was an ancient kingdom located on the southern and central parts of the Korean Peninsula. It is one of the Three Kingdoms of Korea, alongside Goguryeo and Baekje. Silla is known for its significant role in unifying the Korean Peninsula in 668 AD, under the leadership of King Munmu of Silla. This unification marked the beginning of the North-South States Period, with Silla in the south and Balhae in the north.
History[edit]
Silla was founded by Hyeokgeose of Silla in 57 BC, according to the Samguk Sagi, a historical record of the Three Kingdoms of Korea. Initially, it was a small state, but it gradually expanded its territory by conquering nearby states and tribes. Silla's rise to power was significantly aided by its adoption of Buddhism as the state religion in the 6th century, which helped to strengthen its central authority and foster a sense of unity among its people.
In the 7th century, Silla formed an alliance with the Tang Dynasty of China to conquer Goguryeo and Baekje. This military campaign was successful, leading to the unification of the Korean Peninsula under Silla's rule. However, the alliance with the Tang Dynasty soon turned sour, as Silla had to fight to expel Tang forces from the peninsula to secure its independence.
Following unification, Silla entered a golden age, known as the Unified Silla period. This era was marked by significant cultural and technological advancements, including the construction of the famous Bulguksa temple and the Seokguram Grotto, which are now recognized as UNESCO World Heritage Sites.
Culture[edit]
Silla's culture was heavily influenced by Buddhism, which played a central role in the kingdom's art, literature, and architecture. The Hwarang, an elite group of male youth, were instrumental in spreading Buddhist values throughout the kingdom, as well as serving as military leaders and government officials.
The kingdom was also known for its advancements in science, particularly in astronomy and metallurgy. The Cheomseongdae observatory, considered to be one of the oldest astronomical observatories in East Asia, is a testament to Silla's scientific achievements.
Fall of Silla[edit]
Despite its achievements, Silla began to decline in the late 8th century due to internal strife, corruption, and revolts. The kingdom was weakened further by the resurgence of Baekje and Goguryeo, which had been reestablished by the leaders of regional rebellions. In 935, Silla was finally absorbed by the emerging Goryeo Dynasty, marking the end of its nearly 1000-year history.
Legacy[edit]
Silla's legacy is evident in modern South Korea, where its history and culture are celebrated. The kingdom's contributions to Korean art, science, and government are recognized as foundational elements of Korean identity. Silla's successful unification of the Korean Peninsula remains a significant event in Korean history, symbolizing the potential for unity and cooperation among the Korean people.
Ad. Transform your life with W8MD's
GLP-1 weight loss injections special from $29.99


W8MD Medical Weight Loss, Sleep and Medspa offers physician-supervised medical weight loss programs: NYC medical weight loss Philadelphia medical weight loss
Affordable GLP-1 Weight Loss ShotsAffordable GLP-1 Weight Loss Shots
Budget GLP-1 injections NYC (insurance & self-pay options) Popular treatments:
- Semaglutide starting from $29.99/week
- Tirzepatide starting from $45.00/week
✔ Most insurances accepted for visits ✔ Prior authorization support when eligible
Start your physician weight loss NYC journey today:
📍 NYC: Brooklyn weight loss center 📍 Philadelphia: Philadelphia weight loss center
📞 Call: 718-946-5500 (NYC) | 215-676-2334 (Philadelphia)
Tags: Affordable GLP1 weight loss NYC, Wegovy NYC, Zepbound NYC, Philadelphia medical weight loss
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
